Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

Published:1999-08 Issue:4 Volume:12 Page:341-347
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Osato Michael S.,Reddy Rita,Graham David Y.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference61 articles.

1. Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance;Graham;Am. J. Gastroenterol.,1996

2. Factors influencing the eradication of Helicobacter pylori with triple therapy;Graham;Gastroenterology,1992

3. Clarithromycin for treatment of Helicobacter pylori infections;Graham;Eur. J. Gastroenterol. Hepatol.,1995

4. Treatment of Helicobacter pylori infection in humans: a review of the world literature;van der Hulst;Helicobacter,1996

5. Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infection;Yousfi;Aliment. Pharmacol. Ther.,1995

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection;Clinical Nutrition ESPEN;2019-12

2. Macrolide antibiotics;Meyler's Side Effects of Drugs;2016

3. Antibiotic Resistance of Helicobacter pylori Among Male United States Veterans;Clinical Gastroenterology and Hepatology;2015-09

4. Comparison of Helicobacter pylori eradication rates of standard 14-day quadruple treatment and novel modified 10-day, 12-day and 14-day sequential treatments;European Journal of Internal Medicine;2014-03

5. Expression comparison of azithromycin and clarithromycin in triple-therapy regimens for eradication of Helicobacter pylori in hemodialysis patients;Saudi Journal of Kidney Diseases and Transplantation;2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3